Livingstone Health Holdings Limited – Full Utilisation of Rights cum Warrants Proceeds
Livingstone Health Holdings Limited Announces Full Utilisation of Rights cum Warrants Proceeds
Singapore, 1 December 2025 – Livingstone Health Holdings Limited (“Livingstone Health” or the “Company”) announced today a significant development regarding the use of proceeds raised from its recent Rights cum Warrants Issue, a matter of keen interest to existing and potential shareholders.
Key Points from the Report
- Completion of Fund Utilisation: As of 1 December 2025, Livingstone Health has fully utilised the net proceeds generated from its Rights cum Warrants Issue.
- Strategic Acquisition: The remaining balance of S\$322,000 from the net proceeds has been deployed as the purchase consideration for acquiring a 20% stake in Affinity Surgery Centre Pte. Ltd. This acquisition was previously detailed in the Company’s announcement dated 21 November 2025.
- Breakdown of Proceeds:
- Business growth, acquisitions, and expansion: S\$303,000 (brought forward) + S\$19,000 (from recent warrant exercises) = S\$322,000 (fully utilised).
- No proceeds were allocated to general working capital requirements in this latest utilisation.
- The S\$19,000 in additional proceeds came from the exercise of 747,856 warrants at S\$0.025 per share, as announced on 14 October and 17 November 2025.
- Full Deployment: As of the date of this announcement, there are no unutilised net proceeds remaining from the Rights cum Warrants Issue.
Details for Shareholders and Potentially Price-Sensitive Information
- Completion of Capital Deployment: The Company has now fully executed its capital allocation plan as previously communicated to shareholders, with all funds from the Rights cum Warrants Issue deployed for business expansion—specifically, the acquisition of a strategic 20% stake in Affinity Surgery Centre Pte. Ltd.
- Potential Impact on Share Value: This acquisition could be price sensitive as it signals Livingstone Health’s commitment to expanding its healthcare portfolio, which may enhance revenue streams and strengthen its market position in Singapore’s private healthcare sector.
- Transparency and Governance: The Company has adhered to its stated intentions for the use of proceeds as disclosed in the Offer Information Statement, ensuring transparency and good governance practices.
- Warrant Exercises: The recent exercise of warrants, resulting in additional proceeds of S\$19,000, reflects ongoing shareholder engagement and may have a minor dilutive effect, but also demonstrates investor confidence in the Company’s growth strategy.
- No Further Updates Expected: With the full utilisation of proceeds, future updates regarding the specific use of funds from this Rights cum Warrants Issue are not expected unless there are subsequent capital-raising activities or material developments from the Affinity Surgery Centre acquisition.
Summary Table of Proceeds Utilisation
| Intended Use of Net Proceeds |
B/F (S\$’000) |
Additional Proceeds (S\$’000) |
Amount Utilised (S\$’000) |
Balance (S\$’000) |
| General working capital requirements |
– |
– |
– |
– |
| Business growth, acquisitions and expansion |
303 |
19 |
(322) |
– |
| Total |
303 |
19 |
(322) |
– |
Conclusion
The full allocation of proceeds to a strategic acquisition underscores Livingstone Health’s proactive steps towards business growth and sectoral expansion. Shareholders should monitor the performance and integration of Affinity Surgery Centre Pte. Ltd. into the Group’s operations, as this could have a meaningful impact on future financial results and share performance.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research and consult professional advisors before making any investment decisions. The information presented is based on the Company’s official announcement and is subject to change without notice.
View Livingstone Historical chart here
